⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRXS News
Neuraxis, Inc.
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
globenewswire.com
NRXS
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
globenewswire.com
NRXS